- Home
- IBG vs NUWE Comparison
IBG vs NUWE Comparison
Compare IBG & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBG
- NUWE
- Stock Information
- Founded
- IBG 2018
- NUWE 1999
- Country
- IBG Australia
- NUWE United States
- Employees
- IBG N/A
- NUWE N/A
- Industry
- IBG Beverages (Production/Distribution)
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IBG Consumer Staples
- NUWE Health Care
- Exchange
- IBG Nasdaq
- NUWE Nasdaq
- Market Cap
- IBG 5.4M
- NUWE 3.9M
- IPO Year
- IBG 2024
- NUWE N/A
- Fundamental
- Price
- IBG $0.57
- NUWE $5.22
- Analyst Decision
- IBG Strong Buy
- NUWE
- Analyst Count
- IBG 1
- NUWE 0
- Target Price
- IBG N/A
- NUWE N/A
- AVG Volume (30 Days)
- IBG 529.3K
- NUWE 255.1K
- Earning Date
- IBG 08-26-2025
- NUWE 08-14-2025
- Dividend Yield
- IBG N/A
- NUWE N/A
- EPS Growth
- IBG N/A
- NUWE N/A
- EPS
- IBG N/A
- NUWE N/A
- Revenue
- IBG $2,931,243.00
- NUWE $8,318,000.00
- Revenue This Year
- IBG N/A
- NUWE $6.53
- Revenue Next Year
- IBG N/A
- NUWE $51.63
- P/E Ratio
- IBG N/A
- NUWE N/A
- Revenue Growth
- IBG N/A
- NUWE N/A
- 52 Week Low
- IBG $0.44
- NUWE $4.82
- 52 Week High
- IBG $3.35
- NUWE $175.98
- Technical
- Relative Strength Index (RSI)
- IBG 41.82
- NUWE 33.36
- Support Level
- IBG $0.54
- NUWE $4.82
- Resistance Level
- IBG $0.72
- NUWE $6.72
- Average True Range (ATR)
- IBG 0.07
- NUWE 0.44
- MACD
- IBG -0.01
- NUWE 0.21
- Stochastic Oscillator
- IBG 10.71
- NUWE 21.05
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.